http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#head http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#assertion http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#provenance http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#publicationInfo http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#assertion http://bio2rdf.org/drugbank:DB00705 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00705_DB01198 http://bio2rdf.org/drugbank:DB01198 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00705_DB01198 http://bio2rdf.org/drugbank_resource:DB00705_DB01198 http://purl.org/dc/terms/identifier drugbank_resource:DB00705_DB01198 http://bio2rdf.org/drugbank_resource:DB00705_DB01198 http://purl.org/dc/terms/title DDI between Delavirdine and Zopiclone - Delavirdine, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if delavirdine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00705_DB01198 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00705_DB01198 http://www.w3.org/2000/01/rdf-schema#label DDI between Delavirdine and Zopiclone - Delavirdine, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if delavirdine is initiated, discontinued or dose changed. [drugbank_resource:DB00705_DB01198] http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#provenance http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#publicationInfo http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#signature.MCwCFDPD07MG-5cv http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#signature.MCwCFDPD07MG-5cv http://purl.org/nanopub/x/hasSignature MCwCFDPD07MG+5cv9AdYAkTgGgMfMGq8AhRNJ807lUgX5DL+VuKeeHdteUw+wg== http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#signature.MCwCFDPD07MG-5cv http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://purl.org/dc/terms/created 2018-03-30T11:13:03.887+02:00 http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q#signature.MCwCFDPD07MG-5cv http://bio2rdf.org/drugbank_resource:DB00705_DB01198_nanopub.RA9HW2YM0qfE79L_ms5WnSZTGuVgYut7qnW-hEXk8dI6Q http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234